Balaxi Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 17.17 | 9.97 | 14.07 |
| Operating Expense | 16.17 | 10.30 | 11.06 |
| Net Profit | 0.19 | -1.18 | 1.74 |
| Net Profit Margin | 1.11 | -11.84 | 12.37 |
| Earning Per Share | 0.04 | -0.21 | 0.32 |
| EBIDTA | 1.01 | -0.30 | 3.03 |
| Effective Tax Rate | 8 | -24.24 | 20.27 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 17.17 |
| Operating Expense | 16.17 |
| Net Profit | 0.19 |
| Net Profit Margin | 1.11 |
| Earning Per Share | 0.04 |
| EBIDTA | 1.01 |
| Effective Tax Rate | 8.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 60.99 | 70.20 | 108.14 |
| Operating Expenses Annual | 58.56 | 64.96 | 91.32 |
| Operating Profit Annual | 7.80 | 7.63 | 23.43 |
| Interest Annual | 2.06 | 1.54 | 0.46 |
| Depreciation | 0.46 | 0.51 | 0.52 |
| Net Profit Annual | 3.60 | 3.65 | 16.22 |
| Tax Annual | 1.69 | 1.93 | 6.23 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 60.99 |
| Operating Expenses Annual | 58.56 |
| Operating Profit Annual | 7.80 |
| Interest Annual | 2.06 |
| Depreciation | 0.46 |
| Net Profit Annual | 3.60 |
| Tax Annual | 1.69 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 44.06 | 17.87 | 0.84 |
| Cash Flow from Operations | -7.60 | -1.83 | -7.07 |
| Cash Flow from Investing | -24.98 | 0.46 | -2.29 |
| Cash Flow from Financing | 17.21 | 27.55 | 26.39 |
| Cash Flow at the End | 28.68 | 44.06 | 17.88 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 44.06 |
| Cash Flow from Operations | -7.60 |
| Cash Flow from Investing | -24.98 |
| Cash Flow from Financing | 17.21 |
| Cash Flow at the End | 28.68 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 13.08 | 11.04 | 21.71 |
| PBIT Margin (%) | 12.33 | 10.31 | 21.23 |
| PBT Margin (%) | 6.82 | 4.10 | -20.40 |
| Net PROFIT Margin (%) | 5.90 | 5.20 | 15.00 |
| Return On Networth / Equity (%) | 2.89 | 3.42 | 21.62 |
| Return On Networth /Employed (%) | 5.06 | 5.99 | 27.93 |
| Return On Assets (%) | 2.42 | 3.02 | 19.80 |
| Total Debt / Equity (X) | 0.19 | 0.13 | 0.10 |
| Asset Turnover Ratio (%) | 0.41 | 0.58 | 1.32 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 13.08 |
| PBIT Margin (%) | 12.33 |
| PBT Margin (%) | 6.82 |
| Net PROFIT Margin (%) | 5.90 |
| Return On Networth / Equity (%) | 2.89 |
| Return On Networth /Employed (%) | 5.06 |
| Return On Assets (%) | 2.42 |
| Total Debt / Equity (X) | 0.19 |
| Asset Turnover Ratio (%) | 0.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 6.67 | 7.10 | 7.89 |
| Total Current Assets Annual | 119.60 | 122.90 | 99.02 |
| Non Current Assets Annual | 54.84 | 31.46 | 30.70 |
| Total Shareholders Funds Annual | 127.85 | 121.55 | 92.11 |
| Total Assets Annual | 174.45 | 154.36 | 129.72 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 6.67 |
| Total Current Assets Annual | 119.60 |
| Non Current Assets Annual | 54.84 |
| Total Shareholders Funds Annual | 127.85 |
| Total Assets Annual | 174.45 |
EPS (INR)
Expected
0.05
Reported
0.05
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -0.64%
Sep 2024
EPS beaten by 0.00%
